Vaxcyte Overview
Vaxcyte Target Price
Analysts' 12-month price predictions for PCVX.
Share Price
$33.25
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-11-06 | JefferiesRoger Song | $146 |  339.1% upside |  |
| 2024-11-06 | Leerink PartnersDavid Risinger | $135 | 306% upside | |
| 2024-09-10 | Mizuho SecuritiesSalim Syed | $163 | 390.2% upside | |
| 2024-09-04 | Bank of America SecuritiesJason Gerberry | $140 | 321.1% upside | |
| 2024-09-03 | Leerink PartnersDavid Risinger | $153 | 360.2% upside | |
| 2024-09-03 | BTIGTom Shrader | $160 | 381.2% upside | |
| 2024-09-03 | JefferiesRoger Song | $129 | 288% upside | |
| 2024-09-03 | Mizuho SecuritiesSalim Syed | $113 | 239.8% upside | |
| 2024-08-07 | BTIGTom Shrader | $98 | 194.7% upside | |
| 2023-01-03 | Needham | $58 | 74.4% upside | |
| 2022-12-16 | Leerink Partners | $60 | 80.5% upside | |
| 2022-12-15 | Guggenheim | $66 | 98.5% upside | |
| 2022-11-17 | BTIG | $69 | 107.5% upside | |